Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by an autosomal dominant variant in the PROM1 gene.
Biomarker and diagnostic research for PROM1-related dominant retinopathy has been reported in the published literature.
No clinical trials have been registered for PROM1-related dominant retinopathy.
5 publications have been identified in PubMed for PROM1-related dominant retinopathy. Research spans Basic Science / Preclinical (60%), Other (20%), and Diagnostic / Biomarker (20%).
D'Esposito F (2025). [PMID: 41300751](https://pubmed.ncbi.nlm.nih.gov/41300751/). *Genes (Basel)*. [Basic Science / Preclinical]
Merle DA (2025). [PMID: 40767444](https://pubmed.ncbi.nlm.nih.gov/40767444/). *Invest Ophthalmol Vis Sci*. [Diagnostic / Biomarker]
Bhattacharya S (2024). [PMID: 39513868](https://pubmed.ncbi.nlm.nih.gov/39513868/). *Cells*. [Basic Science / Preclinical]
Wright GA (2024). [PMID: 38927596](https://pubmed.ncbi.nlm.nih.gov/38927596/). *Genes (Basel)*. [Other]
Puertas-Neyra K (2024). [PMID: 38956727](https://pubmed.ncbi.nlm.nih.gov/38956727/). *Stem Cell Res Ther*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:51 AM UTC
Common questions about PROM1-related dominant retinopathy